Omada Health (OMDA) CFO records option exercises and share sales under 10b5-1
Filing Impact
Filing Sentiment
Form Type
4/A
Rhea-AI Filing Summary
Omada Health, Inc.’s Chief Financial Officer Steven L. Cook reported a corrected set of insider transactions combining stock option exercises with same-day share sales. On June 24–25, 2026, he exercised options for a total of 2,900 shares of common stock at $8.01 per share and sold the same number of shares in open-market trades at weighted average prices of about $19.02 per share under a Rule 10b5-1 trading plan. Following these transactions, he directly held 187,209 shares of Omada Health common stock. This Form 4/A fully restates an earlier filing by adding the previously omitted option exercises and updating the post-transaction share balance that had been understated.
Positive
- None.
Negative
- None.
Insider Trade Summary 10b5-1
Net Seller: 2,900 shares ($55,146)
Net Sell
6 txns
Insider
Cook Steven L.
Role
Chief Financial Officer
Sold
2,900 shs ($55K)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Option (Right to Buy) | 300 | $0.00 | -- |
| Exercise | Common Stock | 300 | $8.01 | $2K |
| Sale | Common Stock | 300 | $19.0033 | $6K |
| Exercise | Stock Option (Right to Buy) | 2,600 | $0.00 | -- |
| Exercise | Common Stock | 2,600 | $8.01 | $21K |
| Sale | Common Stock | 2,600 | $19.0173 | $49K |
Holdings After Transaction:
Stock Option (Right to Buy) — 40,261 shares (Direct);
Common Stock — 187,509 shares (Direct)
Footnotes (1)
- This Form 4/A restates in its entirety the original Form 4 filed on 6/26/2026 to report exercise transactions that were inadvertently omitted from the original filing. The exercises reported herein were part of same-day exercise-and-sale transactions, and the corresponding sales were timely reported in the original Form 4. Due to the omission of these exercise transactions, the amount of securities beneficially owned following the sales was understated. The amount of securities beneficially owned has been adjusted in Box 5 of Table I of this Form 4/A to correct the aforementioned error. Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 14, 2026. This transaction was executed in multiple trades at prices ranging from $19.00 to $19.04. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $19.00 to $19.01. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. 1/48th of the shares subject to the option vest on each monthly anniversary measured from February 1, 2024 (the "Vesting Commencement Date"), such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date.
Key Figures
Shares sold: 2,900 shares
Sale price: $19.0173/share
Sale price: $19.0033/share
+5 more
8 metrics
Shares sold
2,900 shares
Total common shares sold in open-market trades on June 24–25, 2026
Sale price
$19.0173/share
Weighted average price for 2,600 shares sold on June 24, 2026
Sale price
$19.0033/share
Weighted average price for 300 shares sold on June 25, 2026
Options exercised
2,900 shares
Common stock acquired via option exercises on June 24–25, 2026
Exercise price
$8.01/share
Exercise or conversion price of stock options into common stock
Post-transaction holdings
187,209 shares
Common shares directly owned after the reported transactions
Remaining options
40,261 options
Stock option balance after June 25, 2026 exercise entry
Option expiration
February 8, 2034
Expiration date for the reported stock option grant
Key Terms
Rule 10b5-1 trading plan, exercise-and-sale transactions, Stock Option (Right to Buy), weighted average price, +1 more
5 terms
Rule 10b5-1 trading plan regulatory
"Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 14, 2026."
A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.
exercise-and-sale transactions financial
"The exercises reported herein were part of same-day exercise-and-sale transactions, and the corresponding sales were timely reported in the original Form 4."
Stock Option (Right to Buy) financial
"Stock Option (Right to Buy) transaction reported with an exercise or conversion price of $8.0100."
weighted average price financial
"This transaction was executed in multiple trades at prices ranging from $19.00 to $19.04. The price reported above reflects the weighted average price."
Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.
beneficially owned regulatory
"Due to the omission of these exercise transactions, the amount of securities beneficially owned following the sales was understated."
Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.
